ResearcherEast China University of Science and TechnologyActive in the last 2 years

Yee Lin Tang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4813-3809; OpenAlex author ID A5112462174. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2024: 2 papers · 2025: 1 paper

Papers 3

Pancreatic Cancer-Targeting Cascade Nanoamplifier Enables Self-Replenishing H2O2 Generation and Autophagy Disruption in Chemodynamic Therapy. Co-author DOI 10.3390/pharmaceutics17091201 ↗
FDA-Approved Hydrogel-Mediated In Situ Sonodynamic and Chemotherapeutic Therapy for Pancreatic Cancer. Co-author DOI 10.3390/ph17121666 ↗
ZIP4: a promising early diagnostic and therapeutic targets for pancreatic cancer. Co-author DOI 10.62347/avym3477 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hui Li · 1 shared paper, 2025 · strength 0.28
- Paper Pancreatic Cancer-Targeting Cascade Nanoamplifier Enables Self-Replenishing H2O2 Generation and Autophagy Disruption in… DOI 10.3390/pharmaceutics17091201 ↗
Yuan Ji · 1 shared paper, 2025 · strength 0.28
- Paper Pancreatic Cancer-Targeting Cascade Nanoamplifier Enables Self-Replenishing H2O2 Generation and Autophagy Disruption in… DOI 10.3390/pharmaceutics17091201 ↗
Jiaqi Yu · 1 shared paper, 2025 · strength 0.28
- Paper Pancreatic Cancer-Targeting Cascade Nanoamplifier Enables Self-Replenishing H2O2 Generation and Autophagy Disruption in… DOI 10.3390/pharmaceutics17091201 ↗
Hui Li · 1 shared paper, 2024 · strength 0.28
- Paper FDA-Approved Hydrogel-Mediated In Situ Sonodynamic and Chemotherapeutic Therapy for Pancreatic Cancer. DOI 10.3390/ph17121666 ↗
Yingsheng Cheng · 1 shared paper, 2024 · strength 0.28
- Paper FDA-Approved Hydrogel-Mediated In Situ Sonodynamic and Chemotherapeutic Therapy for Pancreatic Cancer. DOI 10.3390/ph17121666 ↗
Jian Wang · 1 shared paper, 2024 · strength 0.28
- Paper FDA-Approved Hydrogel-Mediated In Situ Sonodynamic and Chemotherapeutic Therapy for Pancreatic Cancer. DOI 10.3390/ph17121666 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.